Skip to main content

局部麻醉軟膏含有利多卡因,按照《防毒包裝法》(PPPA)的規定,包裝必須防止兒童開啟。但是該軟膏包裝不能防止兒童開啟,對幼兒構成中毒風險。

  • Recalled Scalpa Numb Maximum Strength Topical Anesthestic Cream
  • Recalled Scalpa Numb Maximum Strength Topical Anesthestic Cream - Package Front
  • Recalled Scalpa Numb Maximum Strength Topical Anesthestic Cream - Code, UPC and Batch Number
  • Recalled Scalpa Numb Maximum Strength Topical Anesthestic Cream - Expiration Date
  • Recalled Scalpa Numb Maximum Strength Topical Anesthestic Cream – Side View
Name of Product:
局部麻醉軟膏含有利多卡因,按照《防毒包裝法》(PPPA)的規定,包裝必須防止兒童開啟。但是該軟膏包裝不能防止兒童開啟,對幼兒構成中毒風險。
Hazard:

局部麻醉軟膏含有利多卡因,按照《防毒包裝法》(PPPA)的規定,包裝必須防止兒童開啟。但是該軟膏包裝不能防止兒童開啟,對幼兒構成中毒風險。

補救措施:
Refund
Recall Date:
January 14, 2021

產品召回細節

Manufactured In:
China
產品召回號碼:
21-719
Choose Your Recall Emails Get Notified About Each Recall via Email.
About the U.S. CPSC
The U.S. Consumer Product Safety Commission (CPSC) is charged with protecting the public from unreasonable risks of injury or death associated with the use of thousands of types of consumer products. Deaths, injuries, and property damage from consumer product incidents cost the nation more than $1 trillion annually. CPSC’s work to ensure the safety of consumer products has contributed to a decline in the rate of deaths and injuries associated with consumer products over the past 40 years. Federal law bars any person from selling products subject to a publicly announced voluntary recall by a manufacturer or a mandatory recall ordered by the Commission.
For lifesaving information:
SaferProducts.gov